NCT07838675Recruiting
MediPD: An Online Mediterranean Diet Program for People Living With Parkinson's Disease
Feasibility Of An Online Self-management Mediterranean Diet Program To Improve Dietary Behaviour And Quality Of Life For People Living With Parkinson's Disease: The MediPD Pilot Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The aim of this pilot study is to assess whether an online Mediterranean diet programme called MediPD is acceptable and practical for people living with Parkinson's disease, and whether it can help them make and maintain changes towards a Mediterranean-style diet. The study will include 120 adults living in the United Kingdom with Parkinson's disease who have access to an internet-enabled device and currently have low adherence to a Mediterranean-style diet. Participants will be randomly assigned to one of two groups. One group will receive access to the MediPD online programme, which includes short educational videos, personalised dietary information, practical resources, goal-setting tools, and online dietetic support. The other group will continue with their usual care and will receive access to MediPD after completing the final study assessment. Researchers will compare the groups to see whether MediPD improves adherence to a Mediterranean diet after 24 weeks. The study will also examine dietary intake, non-motor symptoms, quality of life, gastrointestinal symptoms, cognitive function, and how acceptable and practical the programme is to use. Assessments will take place at the start of the study, at 12 weeks, and at 24 weeks.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 10 Sept 2026
- Start date
- 10 Oct 2026
- Primary completion date
- 30 Aug 2027
- Lead sponsor
- Queen's University, Belfast
- Diseases
- Parkinson disease
- NCT number
- NCT07838675
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 10 Oct 2026 to the primary completion date, 30 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving prescribed nutritional support
- Participation in an investigational medicinal product trial within the previous 90 days where this may affect study outcomes or participant burden
- Previous participation in a My Moves Matter dietary programme.
Other illness
- Significant cognitive impairment, defined as T-CogS ≤21
- Active inflammatory bowel disease
- Food allergies that would prevent adherence to a Mediterranean-style diet
Other
- Atypical or secondary parkinsonism
- Living in an institution
- Self-reported body mass index \<18.5 kg/m²
- High risk of malnutrition, defined as MUST score ≥2
- Pregnancy
- Dysphagia requiring a pureed diet
- Following a vegan diet that would prevent adherence to the study's Mediterranean-style dietary intervention.
- Current participation in another interventional trial
Who the study is looking for
- Self-reported idiopathic Parkinson's disease
- Age 18 years or older
- Community-dwelling and resident in the United Kingdom
- Access to an internet-enabled device and an active email address
- Mediterranean Diet Score ≤7/13, indicating low adherence to a Mediterranean diet
- Proficient in English
- Able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Remote assessments from Centre for Public Health, Queens University Belfast Coordinator of this site? Confirm its status | Belfast | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.